Daily Dose - May 2nd, 2024
 
 
Daily Dose | View online
 
May 2, 2024
In coming years, additional regulations and guidelines may set the expectation that pharma teams are implementing more digital plant solutions. Therefore, preparing for that future means starting to implement digital technologies today, beginning with fit-for-purpose DCS and MES solutions. By selecting a system inherently designed to support ALCOA+ guidelines for GMP applications, drugmakers will have completed a critical step toward ensuring data integrity practices, which will also promote safe and efficient production.
The company will lay off 300 employees and close two plants as part of the "next phase" of its comprehensive operational restructuring.
Amid a challenging first quarter, Moderna looks to strategically prioritize R&D investments.
Sponsored
Upholding rigorous quality standards is not only a regulatory imperative but also vital for ensuring the efficacy and safety of pharmaceutical products. And as many pharma manufacturers have discovered, enhanced quality processes can also unlock significant performance improvements.But quality improvements...